Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo-Reference-Cited by-同舟云学术

Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo

Published:2020-05-13 Issue:11 Volume:63 Page:6096-6106
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Song Xue-Qing¹,Liu Rui-Ping¹,Wang Shu-Qing¹,Li Zhe¹,Ma Zhong-Ying¹,Zhang Ran¹,Xie Cheng-Zhi¹,Qiao Xin¹,Xu Jing-Yuan¹^ORCID

Affiliation:

1. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China

Funder

National Natural Science Foundation of China

Tianjin Municipal Natural Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00343

Reference85 articles.

1. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer

2. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients

3. Breast cancer

4. Modifiers of risk of hereditary breast cancer

5. CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor α by cAMP

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential Responsive Multifunctional Nanomicelle Effectuates Collective Elimination of Breast Cancer and Cancer Stem Cells;Small;2024-08-30

2. NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy;ACS Applied Materials & Interfaces;2024-07-24

3. Anticancer Activity of Metallodrugs and Metallizing Host Defense Peptides—Current Developments in Structure-Activity Relationship;International Journal of Molecular Sciences;2024-07-03

4. Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling;Bioorganic Chemistry;2024-06

5. Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated Platinum^IV Complexes as Potent Antitumor Agents;Journal of Medicinal Chemistry;2024-05-22